Rooted in Science

Bud & Mary’s honest formulation and production process are built on a solid foundation that meets all high quality standards and GMP (Good Manufacturing Practices) requirements. We understand that a reputable formulation and the efficacy and safety of unfinished products are of the utmost importance.

at our core

High Quality Plant Precision

Our core values guide every decision we make at Bud & Mary’s. From seed to your home, our products are made with the perfect balance of expertise and care, resulting in cannabis products you can be proud to consume.

bud & mary's bird

DEA Licensed

Bud & Mary’s is the first to receive a Cannabis Research License in the United States for clinical trials.

bud & mary's bird

GMP Facility

Bud & Mary’s is the first pharmaceutical-type cannabis company to obtain a GMP and GAP (Good Agricultural Practices) certification in the United States.

Alzheimer’s Disease: A Leading Cause of Death

About the study

  • Small group pilot study (30 patients).
  • World-class research partners including: a neurologist MD, neuro-inflammatory blood biomarker analysis company, and a brain scan company.
  • The first randomized placebo-controlled clinical trial to use and dispense purposefully formulated cannabis-derived medicines.
  • Conducted by Bud & Mary’s in effort  to correlate symptomatic improvements with psychological benefits.
small group pilot study

How Bud & Mary’s Will Investigate the Efficacy of Cannabis in Dementia Patients

Our expertise and innovative testing has allowed us to conduct a clinical trial with a 30 patient randomized and placebo-controlled pilot study to research the symptomatic improvements proper dosing of cannabis has in dementia patients.

bud & mary's bird

World-class research partners

We’ve teamed up with industry experts, including: a neurologist MD, a neuro-inflammatory blood biomarker analysis company, and a brain scan company.

bud & mary's bird

Innovative testing

This study is the first randomized placebo-controlled clinical trial to use and dispense purposefully formulated cannabis-derived medicines.

bud & mary's bird

People first values

Bud & Mary’s conducts this research in effort to correlate symptomatic improvements with psychological benefits.

Why is this important?

Alzheimer’s Disease is the most common form of Dementia and is the 6th leading cause of death in the U.S. There is no known cure for dementia and current support therapies are of limited benefit.

1 in 3
One-third of seniors die with some form of Dementia.
46M
Over 46 million people worldwide have Alzheimer’s Disease. This number is projected to increase to 131 million by 2050.
20y
Dementia symptoms can start up to 20 years after the disease onset making prevention and early detection essential.
$818B
Worldwide cost of Alzheimer’s Disease: $818 billion per year.

Symptoms of Alzheimer's Disease include: memory loss, personality changes, behavioral problems, mood changes, difficulty solving problems and performing tasks, and sleep disturbances.

Good Manufacturing Practices

Formulating the future of Cannabis

Bud & Mary’s is a fully integrated cannabis company with a pharmaceutical approach to cannabis.

Brands by Bud & Mary's

Subscribe
Join our newsletter to stay up to date on features and releases.